Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion type Assertion NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_head.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion description "[Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion evidence source_evidence_literature NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion SIO_000772 10985480 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion wasDerivedFrom befree-20150227 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion wasGeneratedBy ECO_0000203 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.